Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Stiripentol

Brand: Diacomit®
NICE TA: 
Indication: Adjunctive therapy of refractory generalised tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (Dravet syndrome) in combination with clobazam and valproate (under expert supervision)
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No

Background

RED (for all ages) for continuation of treatment of patients who have previously received the drug during childhood under the NHSE standard contract for paediatric neurosciences – neurology.
Not to be newly initiated in adults.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

Stiripentol New Medicine Recommendation (442.7 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red